Log in using OpenID

Asia Pacific Newborn Screening Market

Newborn screening has evolved from a simple urine or blood screening test to a more comprehensive and complex screening system capable of detecting over 50 different conditions.
Asia Pacific Newborn Screening Market - Size,
Share, Outlook, and Opportunity Analysis, 20182026
Newborn screening has evolved from a simple urine or blood screening test to a more
comprehensive and complex screening system capable of detecting over 50 different conditions.
Newborn screening tests measure a number of markers in infant’s blood that can be either
decreased or increased if an infant has certain diseases. Currently, conditions such as cystic
fibrosis (CF), congenital hypothyroidism, phenylketonuria (PKU), and around 22 other metabolic
conditions that affect protein or fat metabolism can be diagnosed through newborn screening
Request Sample Copy of Research Report @
Market Dynamics
Demand for newborn screening is increasing in order to tackle various infectious diseases such
as measles, mumps, polio, tuberculosis, rubella, influenza, whooping cough, chickenpox,
malaria, and streptococcal pharyngitis. According to the World Health Organization (WHO)
2018, globally, around 86% of infants are vaccinated against 26 diseases, however, 19.5 million
infants are unvaccinated resulting in death of 2-3 million children every year.
Screening of newborn is rapidly gaining traction in Asia Pacific region, owing to highest birth
rate in the region, which is almost half of the global population. Therefore, countries in Asia
Pacific are focusing on arranging various workshops to discuss and find solutions for increasing
incidence of neonatal diseases. For instance, from March 30–April 1, 2008, PerkinElmer, Inc.
arranged a workshop on consolidating newborn screening efforts in Cebu, Philippines, in Asia
Pacific region. From June 4-5 in 2010, PerkinElmer, Inc. arranged another workshop in Manila,
Philippines, which included workshop participants such as service providers, policy-makers,
consumer advocates, and researchers from 11 different countries.
Increasing engagement programs by various government healthcare regulatory bodies for
newborn screening and its deployment for wider population base are expected to drive growth
of the market during the forecast period. For instance, in June 2014, PerkinElmer, a company
engaged in the diagnostics, life science research, food, environmental and industrial testing
area, entered into an exclusive collaboration with China's National Health and Family Planning
Commission (NHFPC) to implement a three-year training program for newborn screening.
The National Maternal & Children Health Surveillance Office (NMCHSO) is working with
PerkinElmer, to increase availability and adoption of newborn screening in China, particularly
via expansion in more rural areas.
Report includes chapters which deeply display the following deliverable about industry :
• Asia Pacific Newborn Screening Market Research Objective and Assumption
• Asia Pacific Newborn Screening Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Asia Pacific Newborn Screening Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Asia Pacific Newborn Screening Market, By Regions
• Asia Pacific Newborn Screening Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Asia Pacific Newborn Screening Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Asia Pacific Newborn Screening Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Asia Pacific Newborn Screening Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Moreover, technological advancements in tandem mass spectrometry, colorimetric analysis test,
fluorescence analysis test, enzyme or liquid chromatography, and various immunological assays
and other analysis and high adoption rate of newborn screening with new technology are
factors that are expected to drive growth of the market. In October 2018, LifeCell International,
India’s leading stem cell bank and mother & baby diagnostics company, launched RightStart,
the world’s first Integrated DNA testing for newborn screening to detect over 50 medical
Request For Customization of Research Report @
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Alex Huge
Alex Huge414   documents Email
Health and Medicine
File Size
109 KB
screening, Asia Pacific Newborn Screening Market
Report inappropriate content